Amiodarone Dosing Regimen
For amiodarone therapy, the recommended dosing regimen includes a loading dose of 400-600 mg daily in divided doses for 2-4 weeks, followed by a maintenance dose of 100-200 mg daily to minimize long-term adverse effects. 1
Intravenous Administration for Acute Situations
Life-Threatening Arrhythmias
- Initial dose: 150 mg IV bolus over 10 minutes
- May be repeated in 10-30 minutes if necessary
- Follow with: 1 mg/minute for 6 hours
- Then: 0.5 mg/minute for 18 hours
- Administration considerations:
Oral Administration by Indication
Ventricular Arrhythmias
- Loading dose: 800-1,600 mg/day in divided doses until total of 10g is given
- Maintenance dose: 200-400 mg/day 1, 2
Atrial Fibrillation
- Loading dose: 600-800 mg/day in divided doses until total of 10g is given
- Maintenance dose: 200 mg/day 1, 2
Transition from IV to Oral Therapy
When switching from IV to oral administration, dosing depends on duration of IV therapy:
- IV therapy <1 week: 800-1,600 mg oral amiodarone daily
- IV therapy 1-3 weeks: 600-800 mg oral amiodarone daily
- IV therapy >3 weeks: 400 mg oral amiodarone daily 1
Dosing Considerations and Precautions
Dose Adjustments
- Use lowest effective dose (preferably ≤300 mg/day) when possible 2
- Maximum daily dose: Up to 1,200 mg daily may be considered in inpatient monitoring settings (loading dose) 1
- Reduce dose by 30%-50% when administering with digoxin 1
- Reduce warfarin dose by 50% when co-administered with amiodarone 1
Monitoring Requirements
- Baseline and follow-up (every 3-6 months) thyroid function tests (TSH, free T4, T3)
- Baseline pulmonary function tests including DLCO
- Chest imaging (X-ray or high-resolution CT) at baseline and periodically
- Regular clinical assessment for adverse effects 2
Common Adverse Effects to Monitor
- Cardiovascular: Bradycardia, QT prolongation, hypotension, AV block
- Pulmonary: Cough, dyspnea, interstitial infiltrates (serious complication)
- Gastrointestinal: GI upset, constipation
- Neurological: Tremor, ataxia
- Thyroid: Hypo/hyperthyroidism
- Ophthalmologic: Corneal microdeposits, visual disturbances 1, 2
Important Contraindications
- Severe sinus node dysfunction
- AV block greater than first degree (without pacemaker)
- Cardiogenic shock
- Known hypersensitivity to amiodarone or iodine
- Pregnancy and lactation 2
Amiodarone shows considerable interindividual variation in response, requiring close monitoring and dose adjustment. The drug has a very long half-life (approximately 30 days), which explains the prolonged loading phase and persistent effects after discontinuation 3, 4.
While high-dose amiodarone (600-800 mg/day) has been used historically 5, 6, current guidelines favor lower maintenance doses (100-200 mg daily) to minimize long-term adverse effects while maintaining efficacy 1, 2.
The key to successful amiodarone therapy is balancing efficacy with toxicity through appropriate dosing and vigilant monitoring of potential adverse effects.